Sanofi

SNY· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$42.68-0.63%

2026-08-04

Financials

Valuation Metrics

Sanofi's Market Cap is $102.01B. At end of 2025 it was $136.25B. Ranked #153 of 3,112 in US market (top 5%), #48 of 1,445 on NASDAQ (top 3%), #14 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 5%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	$102.01B	US#153/3,112 Sec#14/269
Revenue	$55.46B	US#132/3,112 Sec#8/269
Net Income	$4.49B	US#80/3,112 Sec#9/269
Total Assets	$151.59B	US#127/3,112 Sec#3/269
Net Assets	$81.29B	US#52/3,112 Sec#2/269
Value
P/E	22.73x	US#396/3,112 Sec#17/269
P/B	1.25x	US#529/3,112 Sec#26/269
P/S	1.84x	US#1,219/3,112 Sec#27/269
EV/EBITDA	8.69x	US#534/3,112 Sec#20/269
FCF Yield	13.02%	US—/3,112 Sec—/269
Profitability
ROE	5.52%	US#1,370/3,112 Sec#57/269
ROA	2.96%	US#903/3,112 Sec#49/269
Op. Margin	14.80%	US#1,344/3,112 Sec#55/269
Revenue Growth	14.58%	US#1,653/3,112 Sec#103/269
Earnings Growth	-91.29%	US#1,587/3,112 Sec#49/269
Financial Health
Debt Ratio	85.96%	US#833/3,112 Sec#156/269
Total Debt	$27.69B	US#202/3,112 Sec#12/269
FCF	$13.29B	US—/3,112 Sec—/269
Cash	$7.46B	US#156/3,112 Sec#8/269
Current Ratio	0.99x	US#2,273/3,112 Sec#260/269
Net Debt/EBITDA	1.44x	US#1,091/3,112 Sec#52/269
Dividend
Div. Yield	5.58%	US—/3,112 Sec—/269
Div. Growth	14.49%	US#361/3,112 Sec#5/269
Performance
1Y Return	-11.18%	US#2,374/3,112 Sec#210/269
1M Return	-1.11%	US#1,725/3,112 Sec#82/269
From 52W High	-18.98%	US#1,628/3,112 Sec#100/269
1Y MDD	-21.04%	US#771/3,112 Sec#35/269
Trading
Volume	2,256,533 shares	US#716/3,112 Sec#63/269
Trading Value	$96M	US#843/3,112 Sec#50/269
Per Share
EPS	$3.46	US#887/3,112 Sec#26/269
BPS	$31.64	US#814/3,112 Sec#18/269